Counting-based cell-free DNA screening test fails to identify triploidy-A case report

Area of Science:

• Genetics
• Prenatal Diagnostics
• Molecular Biology

Background:

• Noninvasive prenatal testing (NIPT) has emerged as a valuable screening tool in prenatal diagnostics.
• NIPT analyzes cell-free fetal DNA in maternal blood for common chromosomal aneuploidies.

Observation:

• NIPT demonstrates high sensitivity and specificity for detecting trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome).
• Despite its accuracy, NIPT is classified as a screening test, not a definitive diagnostic method.

Findings:

• The performance characteristics of NIPT necessitate careful consideration of its results.
• Interpreting NIPT outcomes requires a thorough understanding of its limitations and potential for false positives/negatives.

Implications:

• Accurate interpretation of NIPT results is crucial for appropriate patient management.
• Genetic counseling is essential to discuss NIPT findings, limitations, and subsequent diagnostic options.
• Clinical decisions should be guided by a combination of NIPT screening and confirmatory diagnostic testing.